Clinical Trials Directory

Trials / Completed

CompletedNCT01264575

ED50 and ED95 of Intrathecal Bupivacaine With or Without Epinephrine for Total Knee Replacement Arthroplasty

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
162 (actual)
Sponsor
Seoul Medical Center · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This prospective randomized double-blind dose-response study is aimed to investigate the ED50 and ED95 of intrathecal bupivacaine with or without epinephrine 100 mcg for total knee replacement arthroplasty.

Detailed description

Patients undergoing total knee replacement arthroplasty are randomly assigned to six bupivacaine dose group (6, 7, 8, 9, 10, 11 mg). Combined spinal-epidural anesthesia would be performed. The dose would be considered as successful if no epidural supplement was required during surgery. A probit analysis will be performed to calculate the ED50 and ED95 of intrathecal bupivacaine with or without epinephrine for total knee replacement arthroplasty. After these measurements, ED50 and ED95 of bupivacaine with epinephrine would be compared with those without epinephrine.

Conditions

Interventions

TypeNameDescription
DRUGintrathecal bupivacaine 6 mg with 100 mcg of epinephrineintrathecal bupivacaine 6 mg with 100 mcg of epinephrine
DRUGintrathecal bupivacaine 7 mg with 100 mcg of epinephrineintrathecal bupivacaine 7 mg with 100 mcg of epinephrine
DRUGintrathecal bupivacaine 8 mg with 100 mcg of epinephrineintrathecal bupivacaine 8 mg with 100 mcg of epinephrine
DRUGintrathecal bupivacaine 9 mg with 100 mcg of epinephrineintrathecal bupivacaine 9 mg with 100 mcg of epinephrine
DRUGintrathecal bupivacaine 10 mg with 100 mcg of epinephrineintrathecal bupivacaine 10 mg with 100 mcg of epinephrine
DRUGintrathecal bupivacaine 11 mg with epinephrine 100 mcgintrathecal bupivacaine 11 mg with epinephrine 100 mcg
DRUGintrathecal bupivacaine 6 mg with 200 mcg of epinephrineintrathecal bupivacaine 6 mg with 200 mcg of epinephrine
DRUGintrathecal bupivacaine 7 mg with 200 mcg of epinephrineintrathecal bupivacaine 7 mg with 200 mcg of epinephrine
DRUGintrathecal bupivacaine 8 mg with 200 mcg of epinephrineintrathecal bupivacaine 8 mg with 200 mcg of epinephrine
DRUGintrathecal bupivacaine 9 mg with 200 mcg of epinephrineintrathecal bupivacaine 9 mg with 200 mcg of epinephrine
DRUGintrathecal bupivacaine 10 mg with 200 mcg of epinephrineintrathecal bupivacaine 10 mg with 200 mcg of epinephrine
DRUGintrathecal bupivacaine 11 mg with 200 mcg of epinephrineintrathecal bupivacaine 11 mg with 200 mcg of epinephrine

Timeline

Start date
2009-12-01
Primary completion
2011-01-01
Completion
2011-01-01
First posted
2010-12-22
Last updated
2012-01-31

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01264575. Inclusion in this directory is not an endorsement.